TrimRx's Blog
CagriSema vs Zepbound: How They Compare
If you are weighing CagriSema against Zepbound, the most important fact is availability: Zepbound (tirzepatide) is FDA approved and you can start it now,…
What Is CagriSema? The Semaglutide-Amylin Combination Explained
CagriSema is an investigational once-weekly injection from Novo Nordisk that combines two drugs in a single shot: semaglutide (the GLP-1 medication in Wegovy and…
Retatrutide Half-Life: How Long It Stays in Your System
Retatrutide has a half-life of about six days. That single number explains a lot: it is why the drug is injected once a week,…
Retatrutide Benefits Beyond Weight Loss: What the Trials Show
Weight loss gets the headlines, but in clinical trials retatrutide has shown effects that reach well past the scale: better blood sugar, less liver…
Retatrutide Dosing: What the Trials Used
First, the part that matters most: retatrutide is an investigational drug that is not FDA approved, and there is no approved dosing for it….
Is Retatrutide FDA Approved? Current Status (2026)
No. As of June 2026, retatrutide is not FDA approved. It remains an investigational drug in Phase 3 clinical trials, which means it cannot…
Retatrutide vs Tirzepatide: How They Compare
Retatrutide and tirzepatide are both once-weekly injections made by Eli Lilly, but they sit at very different points in their life cycle. Tirzepatide (sold…
Retatrutide vs Semaglutide: What’s Different
Semaglutide is the GLP-1 medication most people have heard of, sold as Ozempic and Wegovy and now available as a once-daily pill too. It’s…
Retatrutide Side Effects: What the Trials Show
The most common retatrutide side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. They tend to be mild to moderate, show up mostly during…
